Skip to content

Impact of Hyperoxia During Cardiopulmonary

Impact of Hyperoxia During Cardiopulmonary Bypass in the Occurrence of Cardiovascular Complications After Cardiac Surgery

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02819739
Acronym
CARDIOX
Enrollment
330
Registered
2016-06-30
Start date
2014-11-11
Completion date
2019-03-30
Last updated
2019-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Complications

Brief summary

The hypothesis implies that this work is the use of hyperoxia during cardiopulmonary bypass by his heart preconditioning effect is associated with a lower incidence of cardiac arrhythmias (atrial fibrillation, tachycardia or ventricular fibrillation) and lesions of myocardial ischemia-reperfusion injury in cardiac surgery postoperative.

Interventions

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Major patient ≥ 18 years * Patient operated cardiac surgery for myocardial revascularization (CABG) or surgical correction of valvular or combined surgery (CABG and valve disease) or ascending aortic surgery * Signed Consent * Affiliation to social security

Exclusion criteria

* Permanent atrial fibrillation * Cordarone therapy, * Pregnant woman * Patient under guardianship or trusteeship or private public law * Internal pacemaker * Hypothermia, * Patient refusal, * Cardiac surgery without extracorporal circulation (ECC), * Participation in another study.

Design outcomes

Primary

MeasureTime frame
Occurred within 15 days after surgery, disorders of heart rhythm (atrial fibrillation, tachycardia or ventricular fibrillation)15 days after surgery

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026